90 yttrium-ibritumomab tiuxetan consolidation of first remission in advanced-stage follicular non-Hodgkin lymphoma: Updated results after a median follow-up of 8.5 years from the GOTEL trial.
暂无分享,去创建一个
A. Royuela | J. Chacón | F. Franco | M. Provencio-Pulla | M. Llanos | J. Gomez-Codina | J. Gumà | J. Delgado | R. Álvarez | A. Rueda | F. Arroyo | C. Quero | L. Cruz-Merino